Anpario plc (AIM: ANP)

Market Cap	94.47M
Revenue (ttm)	32.72M
Net Income (ttm)	3.02M
Shares Out	20.45M
EPS (ttm)	0.18
PE Ratio	25.71
Forward PE	18.86
Dividend	0.11 (2.39%)
Ex-Dividend Date	Nov 14, 2024

Volume	56,066
Average Volume	44,447
Open	438.72
Previous Close	437.50
Day's Range	437.50 - 458.89
52-Week Range	220.00 - 458.89
Beta	0.56
RSI	75.90
Earnings Date	Mar 26, 2025

About Anpario

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzy...

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1996
• Employees: 109
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ANP

Financial Performance

In 2023, Anpario's revenue was 31.00 million, a decrease of -6.36% compared to the previous year's 33.10 million. Earnings were 2.53 million, a decrease of -23.46%.